ABSTRACT
A 24 year-old man was admitted with hypertensive crises and diagnosis hypothesis of neurofibromathosis and pheochromocytoma with blood pressure of 150 x 110mmHg and in use of anti-hypertensive drugs. The electrocardiogram (EKG) showed left ventricle hypertrophy. An echocardiogram showed interventricular septum (IVS) thickness of 16mm, posterior wall (PW) thickness of 11mm (ratio IVS/PW was 1.4). Diastolic ventricular diameter was 39mm with gradient of 52mmHg and mild mitral-valve murmur by pulsate Doppler. Increased vanillylmandelic acid and metanephrines in a 24-hour sample of urine has confirmed diagnosis of pheochromocytoma within was localized by 131I metaiodobenzyl-guanidine scan and computerized axial tomography. The patient was submitted to right adrenalectomy. Blood pressure was normalized. Evaluation an year later revealed a healthy man with normal laboratory exams, EKG and echocardiogram. It seems that the hypertrophy was consequence of the hypertension and pheochromocytoma, was not hypertrophic cardiomyopathy.
Subject(s)
Adrenal Gland Neoplasms/diagnosis , Hypertension/etiology , Hypertrophy, Left Ventricular/diagnosis , Pheochromocytoma/diagnosis , Adrenal Gland Neoplasms/complications , Adult , Diagnostic Errors , Echocardiography , Electrocardiography , Humans , Hypertrophy, Left Ventricular/complications , Male , Pheochromocytoma/complications , PrognosisABSTRACT
PURPOSE--To evaluate if the levels of lipoprotein (a) [Lp(a)], apolipoproteins (apo) A1, B and the lipid profile (LP) differ among heart transplantation (HT) patients, with coronary artery disease (CAD) and patients without CAD (NL) and if LP discriminates patients with graft vascular disease (GVD). METHODS--A hundred and seventy patients separated in 3 groups: I) HT [n = 43 46 +/- 15 years, 24 months (median) after transplantation], of these 28 were submitted to serial angiography after the first year of transplantation subgroups with GVD (n = 9) and without GVD (NGVD) (n = 19); II) CAD (n = 72, 48 +/- 6 years); III) NL (n = 45, 50 +/- 6 years). RESULTS--HT presented higher apo A1 levels than CAD and NL (1.5 +/- 0.5 vs 1.2 +/- 0.05 vs 1.1 +/- 0.06 g/l p < 0.05 respectively). Apo B was higher on CAD than in HT and NL (1.5 +/- 0.05 vs 1.2 +/- 0.07 vs 1.3 +/- 0.09 g/l p < 0.05). Lp (a) presented a trend to higher levels in HT and CAD than in NL [25(2-97), 24(1-130) and 15 (1-100) mg/dl, p = 0.05)]. However, when individually evaluated against NL Lp(a) levels were higher in HT and CAD (p = 0.019 and 0.03 respectively). LP did not differ between GVD and NGVD. CONCLUSION--Increased Lp(a) levels after transplantation might be related to the high prevalence of GVD. The LP did not discriminate GVD.
Subject(s)
Apolipoprotein A-I/blood , Apolipoproteins B/blood , Coronary Disease/etiology , Heart Transplantation/adverse effects , Lipids/blood , Lipoprotein(a)/blood , Adult , Aged , Analysis of Variance , Case-Control Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prevalence , Risk FactorsSubject(s)
Endocarditis, Bacterial/epidemiology , Adolescent , Adult , Age Factors , Brazil , Child , Endocarditis, Bacterial/etiology , Female , Heart Defects, Congenital/complications , Heart Valve Diseases/complications , Humans , Male , Middle Aged , Prognosis , Sex Factors , Staphylococcal Infections/complications , Substance-Related Disorders/complicationsABSTRACT
Apresentamos uma revisao da literatura a respeito da miocardiopatia da distrofia muscular progressiva de Duchenne (DMPD) e procuramos dar uma orientacao objetiva ao medio neurologista a respeito da abordagem cardiologica desses pacientes. Em diversas doencas neuromiopaticas heredofamiliares existe a possibilidade de miocardiopatia, incluindo diversas distrofias musculares nao miotonicas, distrofia miotonica e ataxia de Friedreich. Abordamos nesta publicacao exclusivamente a DMPD